Vynleads is a small wellness technology company focused on metabolic health. Its flagship product, Done With Diabetes, is an app-based subscription program for adults with type 2 diabetes, prediabetes, and related metabolic conditions. The program is not a medical service — it provides lifestyle education, habit-formation support, and accountability tools built around nutrition, movement, and self-monitoring. The core product is structured as a 56-day journey divided into four sequential phases, after which users transition into a maintenance layer called Lifetime Wellness Mode. Features include personalized daily missions, meal guidance, a recipe library, progress tracking, and an AI coaching tool called Dr. Smith AI Coach. Vynleads sells primarily direct-to-consumer through a digitally native model — website traffic, educational content, social media, and performance marketing funnel users into a free trial and then a $29/month paid subscription. Revenue is driven by subscriber count and retention. The company is also pursuing enterprise distribution through self-insured employers, health plans, and payers, though no significant enterprise relationships exist yet. Vynleads has one employee — its CEO — and relies on third-party providers for development and operations. Management envisions Done With Diabetes as the first product in a broader platform that could eventually support additional condition-specific programs, with heart disease and depression cited as possible future areas.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →